Patients prescribed benzodiazepines and opioids by different providers 20% more likely to overdose, adding to already heightened risk.
Study looks at trends before and after 2016 guide for prescribers was released.
The cannabis-derived substance provides fewer side effects, with less potential for abuse.
The findings are a promising step for a disease with limited treatment options.
A new survey shows high usage rates of cannabinoids like CBD for multiple sclerosis, but most patients are figuring out these new products on their own.